WASF3 (Wiskott-Aldrich Syndrome Protein Family Member 3, WASP Family Protein Member 3, Protein WAVE-3, Verprolin Homology Domain-containing Protein 3, KIAA0900, SCAR3, WAVE3) (MaxLight 550), Rabbit
WASF3 (Wiskott-Aldrich Syndrome Protein Family Member 3, WASP Family Protein Member 3, Protein WAVE-3, Verprolin Homology Domain-containing Protein 3, KIAA0900, SCAR3, WAVE3) (MaxLight 550), Rabbit
WASF3 (Wiskott-Aldrich Syndrome Protein Family Member 3, WASP Family Protein Member 3, Protein WAVE-3, Verprolin Homology Domain-containing Protein 3, KIAA0900, SCAR3, WAVE3) (MaxLight 550), Rabbit
Biozol Catalog Number:
USB-W0807-05-ML550
Supplier Catalog Number:
W0807-05-ML550
Alternative Catalog Number:
USB-W0807-05-ML550-100
Manufacturer:
US Biological
Host:
Rabbit
Category:
Antikörper
Application:
WB
Immunogen:
WASF3 (AAH50283.1, 1-499aa) full-length human protein.
MaxLight(TM)550 is a new Yellow-Green photostable dye conjugate comparable to Alexa Fluor(TM)546, 555, DyLight(TM)549 , Cy3(TM), TRITC and offers better labeling efficiency, brighter imaging and increased immunodetection. Absorbance (550nm), Emission (575nm), Extinction Coefficient 150,000. This gene encodes a member of the Wiskott-Aldrich syndrome protein family. The gene product is a protein that forms a multiprotein complex that links receptor kinases and actin. Binding to actin occurs through a C-terminal verprolin homology domain in all family members. The multiprotein complex serves to tranduce signals that involve changes in cell shape, motility or function. Applications: Suitable for use in Western Blot. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: Store product at 4C in the dark. DO NOT FREEZE! Stable at 4C for 12 months after receipt as an undiluted liquid. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Caution: MaxLight(TM)550 conjugates are sensitive to light. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Note: Applications are based on unconjugated antibody.
